1 |
Lee JY, Jeong KW, Shin S, Lee JU, Kim Y. 2009. Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors. Bioorg. Med. Chem. 17: 5408-5413.
DOI
|
2 |
Jeon D, Jeong MC, Jnawali H, Kwak C, Ryoo S, Jung I, et al. 2017. Phloretin exerts anti-tuberculosis activity and suppresses lung inflammation. Molecules 22: 183.
DOI
|
3 |
Jung M, Triebel S, Anke T, Richling E, Erkel G. 2009. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 53: 1263-1280.
DOI
|
4 |
Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48: 1503-1508.
DOI
|
5 |
Bateman SL, Seed P. 2012. Intracellular Macrophage Infections with E. coli under Nitrosative Stress. Bio Protoc. 2: 20.
|
6 |
Rallabhandi P, Awomoyi A, Thomas KE, Phalipon A, Fujimoto Y, Fukase K, et al. 2008. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling. J. Immunol. 180: 1139-1147.
DOI
|
7 |
Vila J, Saez-Lopez E, Johnson JR, Romling U, Dobrindt U, Canton R, et al. 2016. Escherichia coli: an old friend with new tidings. FEMS Microbiol. Rev. 40: 437-463.
DOI
|
8 |
Mainil J. 2013. Escherichia coli virulence factors. Vet. Immunol. Immunopathol. 152: 2-12.
DOI
|
9 |
Bien J, Sokolova O, Bozko P. 2012. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol. 2012
|
10 |
Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. 2019. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 11: 10.
DOI
|
11 |
Kim KS. 2016. Human meningitis-associated Escherichia coli. EcoSal. Plus 7: 10.1128.
|
12 |
Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, et al. 2011. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 79: 4819-4827.
DOI
|
13 |
Gabay C. 2006. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8: 1-6.
DOI
|
14 |
Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. 2001. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69: 5529-55237.
DOI
|
15 |
Mokady D, Gophna U, Ron EZ. 2005. Virulence factors of septicemic Escherichia coli strains. Int. J. Med. Microbiol. 295: 455-462.
DOI
|
16 |
Nathan C. 2002. Points of control in inflammation. Nature 420: 846-852.
DOI
|
17 |
Tasneem S, Liu B, Li B, Choudhary MI, Wang W. 2019. Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacol. Res. 139: 126-140.
DOI
|
18 |
Cheon D, Kim J, Jeon D, Shin HC, Kim Y. 2019. Target proteins of phloretin for its anti-inflammatory and antibacterial activities against propionibacterium acnes-induced skin infection. Molecules 24: 1319.
DOI
|
19 |
Mankhong S, Iawsipo P, Srisook E, Srisook K. 2019. 4-Methoxycinnamyl p-coumarate isolated from Etlingera pavieana rhizomes inhibits inflammatory response via suppression of NF-, Akt and AP-1 signaling in LPS-stimulated RAW 264.7 macrophages. Phytomedicine 54: 89-97.
DOI
|
20 |
Barreca D, Bellocco E, Lagana G, Ginestra G, Bisignano C. 2014. Biochemical and antimicrobial activity of phloretin and its glycosilated derivatives present in apple and kumquat. Food Chem. 160: 292-297.
DOI
|
21 |
Kim J, Durai P, Jeon D, Jung I, Lee S, Park YM, et al. 2018. Phloretin as a potent natural TLR2/1 inhibitor suppresses TLR2-induced inflammation. Nutrients 10: 868. doi:10.3390/nu10070868
DOI
|
22 |
Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. 1996. Studies on immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 50: 69-76.
DOI
|
23 |
Mariadoss AVA, Vinyagam R1, Rajamanickam V, Sankaran V, Venkatesan S, David E. 2019. Pharmacological aspects and potential use of phloretin: A systemic review. Mini. Rev. Med. Chem. 19: 1060-1067.
DOI
|
24 |
Tsao R, Yang R, Young JC, Zhu H. 2003. Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC). J. Agric. Food Chem. 51: 6347-6353.
DOI
|
25 |
Wei Y, Zhang J, Memon AH, Liang H. 2017. Molecular model and in vitro antioxidant activity of a water-soluble and stable phloretin/hydroxypropyl--cyclodextrin inclusion complex. J. Mol. Liq. 236: 68-75.
DOI
|
26 |
Huang WC, Dai YW, Peng HL, Kang CW, Kuo CY, Liou CJ. 2015. Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF- pathway in the TNF--induced HaCaT human keratinocytes. Int. Immunopharmacol. 27: 32-37.
DOI
|
27 |
Petersen HJ, Smith AM. 2013. The role of the innate immune system in granulomatous disorders. Front. Immunol. 4: 120.
DOI
|
28 |
Stangl V, Lorenz M, Ludwig A, Grimbo N, Guether C, Sanad W, et al. 2005. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr. 135: 172-178.
DOI
|
29 |
Xu M, Gu W, Shen Z, Wang F. 2018. Anticancer activity of phloretin against human gastric cancer cell lines involves apoptosis, cell cycle arrest, and inhibition of cell invasion and JNK signalling pathway. Med. Sci. Monit. 4: 6551-6558.
|
30 |
Hirayama D, Iida T, Nakase H. 2017. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int. J. Mol. Sci. 19: pii: E92.
|
31 |
Zhang JM, An J. 2007. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 45: 27-37.
DOI
|
32 |
Kim J, Jacob B, Jang M, Kwak C, Lee Y, Son K, et al. 2019 Development of a novel short 12-meric papiliocin-derived peptide that is effective against gram-negative sepsis. Sci. Rep. 9: 3817.
DOI
|
33 |
Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
DOI
|
34 |
Sharma JN, Al-Omran A, Parvathy SS. 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15: 252-259.
DOI
|
35 |
Lee E, Shin A, Kim Y 2015 Anti-inflammatory activities of cecropin A and its mechanism of action. Arch. Insect Biochem. Physiol. 87: 1-14
DOI
|